Centene Corporation (CNC): financials, SEC filings and peers
Centene Corporation (CNC) is a managed health care company in the Health Care sector of the S&P 500, headquartered in St. Louis, Missouri.
It was founded in 1984 and joined the S&P 500 on March 30, 2016.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Hospital & Medical Service Plans”.
Centene Corporation at a glance
- Revenue (12 months)
- $202.9B
- Revenue growth
- +13.9%
- Operating margin
- -2.8%
- Net income (12 months)
- −$5.1B
- Free cash flow (12 months)
- $9.0B
- Cash
- $24.2B
- Debt
- $16.1B
- Diluted EPS (12 months)
- $-10.44
Twelve months to June 30, 2026, from the 10-Q filed July 28, 2026.
Latest twelve months
Over the twelve months to June 30, 2026, Centene Corporation reported revenue of $202.9 billion, up 13.9% from a year earlier.
Its operating margin was -2.8%, down 3.9 percentage points from a year earlier: for every $100 of sales, about $0 was left as operating profit.
Centene Corporation reported a net loss of $5.1 billion over the period.
Profit fell while sales grew, which usually points to higher costs, heavier investment or one-time items. The filings explain which.
Operating cash flow was $9.7 billion and capital spending $798 million, leaving free cash flow of $9.0 billion (4.4% of revenue).
At the end of the period it held $24.2 billion in cash and $16.1 billion in debt, a net cash position of $8.0 billion.
Five-year trend
- Revenue went from $111.1 billion in fiscal 2020 to $194.8 billion in fiscal 2025, about 11.9% a year.
- Revenue has grown for 5 fiscal years in a row.
- Operating margin narrowed from 2.8% to -3.9% over the same years.
- Free cash flow was negative in 1 of the last 6 fiscal years.
- Centene Corporation reported a net loss in 1 of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $126.0B | $144.5B | $154.0B | $163.1B | $194.8B |
| Revenue growth | 13.4% | 14.7% | 6.5% | 5.9% | 19.4% |
| Operating margin | 1.4% | 0.9% | 1.9% | 1.9% | -3.9% |
| Net income | $1.3B | $1.2B | $2.7B | $3.3B | −$6.7B |
| Free cash flow | $3.3B | $5.3B | $7.3B | −$490M | $4.3B |
| Diluted EPS | $2.28 | $2.07 | $4.95 | $6.31 | $-13.53 |
Fiscal years as reported in Centene Corporation’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 8-K filed September 16, 2026 — Regulation FD disclosure
- 8-K filed August 17, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed July 29, 2026 — Other event
- 8-K filed July 28, 2026 — Earnings results; Executive or director change
- 10-Q filed July 28, 2026 — quarterly report
- 8-K filed June 22, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed May 15, 2026 — Executive or director change; Shareholder vote results
- 8-K filed April 28, 2026 — Earnings results
Companies like Centene Corporation
Other S&P 500 companies in Managed Health Care:
- ELVElevance HealthIndianapolis, Indiana
- HUMHumanaLouisville, Kentucky
- UNHUnitedHealth GroupEden Prairie, Minnesota
More from Health Care
Questions about Centene Corporation
Is Centene Corporation's revenue growing?
Yes. Revenue for the twelve months to June 30, 2026 was $202.9 billion, up 13.9% from a year earlier, according to its SEC filings.
Is Centene Corporation profitable?
Not over the latest twelve months: it reported a net loss of $5.1 billion for the period to June 30, 2026.
Does Centene Corporation have more cash or more debt?
At June 30, 2026 it had $24.2 billion in cash and $16.1 billion in debt, so more cash than debt.
When did Centene Corporation last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on July 28, 2026.
Which companies are similar to Centene Corporation?
In the S&P 500, Centene Corporation is grouped in Managed Health Care within the Health Care sector. Elevance Health (ELV), Humana (HUM), UnitedHealth Group (UNH) are in the same group.
Understand the numbers
Source: Centene Corporation’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.